Up a level |
Journal Article
Miller, K., Albers, P., Eichenauer, R., Geiges, G., Grimm, M-O., Koenig, F., Mickisch, G., Pfister, D., Schwentner, C., Suttmann, H. and Zastrow, S. (2016). Metastatic castration-resistant prostate cancer. Clinical data, new treatment options and therapy monitoring. Urologe, 55 (9). S. 1206 - 1213. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0563
Zastrow, S., Saad, F., Heinrich, D., Gillessen, S., OSullivan, J., Carles, J., Miller, K., Huang, L., Van Tol, Seeger M., Nilsson, S. and Heidenreich, A. (2017). Radium-223 (Ra-223) in sequence or in concurrent use with abiraterone acetate (AA) or enzalutamide (E) in metastatic castration resistant prostate cancer (mCRPC) patients treated in an international early access program (iEAP). Oncol. Res. Treat., 40. S. 94 - 95. BASEL: KARGER. ISSN 2296-5262